Trial Profile
A phase Ib/IIa trial of BIS-001 in epilepsy
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 19 Apr 2016
Price :
$35
*
At a glance
- Drugs Huperzine A (Primary)
- Indications Epilepsy; Seizures
- Focus Adverse reactions; Therapeutic Use
- 19 Apr 2016 New trial record